Imipenem Powder
FDA Label NDC 69806-0093

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Merck Sharp & Dohme Corp. for the product Imipenem (NDC 69806-0093). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding principal display panel - shipping label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Principal Display Panel - Shipping Label

Imipenem

IMIPENEM STERILE USP (CHE)
V.1004.27.0001

Material: 2002448
DoM: 13.01.2015

Batch: 0000452483
Expiry: 12.01.2018

Qty: ***N/A***

Rx only. Caution: For manufacturing, processing, or repacking
Storage: (2 °C)-(8 °C) Container must be at same temperature
as room before opening.
CAN8253SEAL0013705

Merck Sharp & Dohme Corp a subsidiary of Merck & Co Inc. Elkton VA 22827 US 540-298-1211

Made in US.

MERCK

HAZCOM Label Required

STERILE •
THIS CONTAINER CONTAINS STERILE MATERIAL AND SHOULD NOT
BE OPENED EXCEPT UNDER SPECIAL CONDITIONS THAT WILL NOT
AFFECT THE STERILITY OF THE PRODUCT.

MS1016401

Shipping Label (Imipenem 01)

Shipping Label (Imipenem 01)

* Please review the disclaimer below.